导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.18% | 481/1050 |
| 近一周 | -2.31% | 768/1104 |
| 近一月 | -2.43% | 426/1103 |
| 近一季 | -3.56% | 407/1092 |
| 近半年 | -1.19% | 488/1070 |
| 近一年 | 10.15% | 367/1018 |
| 近两年 | 45.09% | 548/926 |
| 近三年 | 26.65% | 429/834 |
| 成立以来 | -13.46% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.44% 587/1070 |
10.81% 530/1101 |
- - |
- - |
| 2025 | 23.69% 605/1065 |
-2.53% 932/1014 |
-0.19% 705/1038 |
24.35% 461/1050 |
2.24% 286/1065 |
| 2024 | 5.72% 405/1011 |
2.07% 209/960 |
1.40% 222/983 |
8.46% 750/991 |
-5.83% 718/1011 |
| 2023 | -13.02% 435/952 |
-1.80% 699/880 |
-1.55% 272/895 |
-5.59% 352/915 |
-4.70% 471/952 |
| 2022 | -29.15% 601/867 |
-20.41% 536/773 |
9.37% 290/806 |
-14.88% 557/845 |
-4.37% 617/867 |
| 2021 | 1.39% 339/740 |
1.69% 95/580 |
4.40% 476/659 |
-9.18% 484/704 |
5.16% 217/740 |
| 2020 | 26.26% 362/554 |
-4.02% 263/419 |
17.67% 321/466 |
4.56% 369/517 |
6.91% 407/554 |
| 2019 | 24.76% 313/410 |
23.04% 835/1146 |
-3.95% 644/1228 |
-0.53% 346/390 |
6.13% 305/410 |
| 2018 | -23.13% 117/349 |
- - |
-6.28% 222/990 |
-2.89% 365/1000 |
-13.67% 801/1080 |
| 2017 | 2.98% 165/285 |
- - |
- - |
- - |
- - |
| 2016 | -8.41% 64/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 博时国企改革股票A VS. 东吴新产业精选股票A(580008) |